Controlled generation of nitric oxide

Details Controlled generation of nitric oxide Controlled generation of nitric oxide

2002-08-28

2011-11-29

Anthony, Joseph D (Department: 1761)

Compositions

Oxidative bleachant, oxidant containing, or generative

Contains inorganic nitrogen containing compound

C252S182340, C424S718000, C424S485000, C424S486000, C424S487000, C424S488000, C424S499000

Reexamination Certificate

active

08066904

ABSTRACT:
Inhalation of low levels of nitric oxide can rapidly and safely decrease pulmonary hypertension in mammals. Precise delivery of nitric oxide at therapeutic levels of 20 to 100 ppm and inhibition of reaction of nitric oxide with oxygen to form toxic impurities such as nitrogen dioxide can provide effective inhalation therapy for pulmonary hypertension.

REFERENCES:
patent: 1021234 (1912-03-01), Muller von Berneck et al.
patent: 2272810 (1942-02-01), Milburn
patent: 4007057 (1977-02-01), Littauer et al.
patent: 4010897 (1977-03-01), Treharne et al.
patent: 4287040 (1981-09-01), Alamaro
patent: 4774069 (1988-09-01), Handley
patent: 4778450 (1988-10-01), Kamen
patent: 5228434 (1993-07-01), Fishman
patent: 5396882 (1995-03-01), Zapol
patent: 5485827 (1996-01-01), Zapol et al.
patent: 5525357 (1996-06-01), Keefer et al.
patent: 5545614 (1996-08-01), Stamler et al.
patent: 5558083 (1996-09-01), Bathe et al.
patent: 5570683 (1996-11-01), Zapol
patent: 5615669 (1997-04-01), Olsson et al.
patent: 5648101 (1997-07-01), Tawashi
patent: 5651358 (1997-07-01), Briend et al.
patent: 5676963 (1997-10-01), Keefer et al.
patent: 5683668 (1997-11-01), Hrabie et al.
patent: 5692495 (1997-12-01), Sheu
patent: 5823180 (1998-10-01), Zapol
patent: 5827420 (1998-10-01), Shirazi et al.
patent: 5839433 (1998-11-01), Higenbottam
patent: 5871009 (1999-02-01), Rydgren et al.
patent: 5873359 (1999-02-01), Zapol et al.
patent: 5994444 (1999-11-01), Trescony et al.
patent: 6046383 (2000-04-01), Elsenga-Boersma et al.
patent: 6103275 (2000-08-01), Seitz et al.
patent: 6109260 (2000-08-01), Bathe
patent: 6158434 (2000-12-01), Lugtigheid et al.
patent: 6190704 (2001-02-01), Murrell
patent: 6261594 (2001-07-01), Smith et al.
patent: 6270779 (2001-08-01), Fitzhugh et al.
patent: 6758214 (2004-07-01), Fine et al.
patent: 7025869 (2006-04-01), Fine et al.
patent: 7040313 (2006-05-01), Fine et al.
patent: 2001/0012851 (2001-08-01), Lundy et al.
patent: 2002/0090401 (2002-07-01), Tucker et al.
patent: 2005/0142218 (2005-06-01), Tucker et al.
patent: 2009/0081279 (2009-03-01), Jezek et al.
patent: 2009/0297634 (2009-12-01), Friedman et al.
patent: WO 94/16740 (1994-08-01), None
patent: WO 01/15738 (2001-03-01), None
Mascarenhas, Oscar Carlton, “Epoxy-Based Medical Grade Adhesive Hydrogels and Nitric Oxide Releasing Polymers”,Dissertation Abstracts International, vol. 55/02-B, pp. 445 (1993).
Pulfer, Sharon Kay, “Nitric Oxide Releasing Polymers and Their Application to Vascular Devices (Polyethyleneimine, Polytetrafluoroethylene)”,Dissertation Abstracts International, vol. 56/12-B, pp. 6727 (1995).
Roselle, Dominick C., et al., “Characterization and Nitric Oxide Release Studies of Lipophilic 1-Substituted Diazen-1-ium-1,2-Diolates”,Journal of Controlled Release, vol. 51, pp. 131-142 (1998).
Smith, Daniel J.,et al., “Nitric Oxide-Releasing Polymers Containing the [N(O)NO]−Group”,Journal of Medicinal Chemistry, vol. 39, No. 5, pp. 1148-1156 (1996).
Taira, Masafumi, et al. “Continuous Generation System for Low-Concentration Gaseous Nitrous Acid”,Analytical Chemistry, vol. 62, No. 6, pp. 630-633, (1990).
Suzuki, “Nitrogen Oxides Generation Method for Recovered Nitric Acid by Electrolysis. An Action Plan for Reduction of Low-Level-Liquid-Waste in Processing Plant”, Kyoto Daigaku Genshiro Jikkensho, (Tech. Rep.) (no month, 1991), KURRI-TR-361, pp. 19-26.
Non-final Office Action dated Apr. 8, 2005 for U.S. Appl. No. 10/229,026, filed Aug. 28, 2002; 17 pages.
International Search Report, 8 pages, Mar. 10, 2004.
Tannenbaum, S.R. et al., “Inhibition of Nitrosamine Formation by Ascorbic Acid,”The American Journal of Clinical Nutrition, American Society of Clinical Nutrition, Bethesda, Maryland, Jan. 1991, vol. 53, pp. 247-250.
Licht, W.R. et al., “Use of Ascorbic Acid to Inhibit Nitrosation: Kinetic and Mass Transfer Considerations for an in Vitro System,”Carcinogenesis, IRL Press At Oxford University Press, Oxford, Mar. 1988, pp. 365-371.

Affiliated with

Also associated with

Rating

Controlled generation of nitric oxide does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Controlled generation of nitric oxide, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Controlled generation of nitric oxide will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4284875